Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Newly developed oral bioavailable EHMT2 inhibitor as a po... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome
0
Authors
Sung Wang
8 more
Sung Wang
•
Yan Xiong
6 more
•
Yong‐Hui Jiang
Published
May 24, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Molecular Therapy
Topics
Biology
Bioinformatics
Genetics
Molecular Biology
Candidate Gene
Show all topics
DOI
10.1016/j.ymthe.2024.05.034
